Skip to main content

Exploring the effects of peri-partum ingestion of traditional medicine on maternal and foetal outcomes: a prospective cohort study

Abstract

Objective

In Africa, 80% of women ingest traditional medicine (TM) during pregnancy. Although widely used in Cameroon, no study in has either demonstrated its safety or effectiveness. Hence, we sought to determine the effects of TM ingestions during the peri-partum period on maternal and foetal outcomes. A cohort study was conducted from January to April 2016 in two referral maternity departments of Cameroon. We consecutively enrolled all consenting parturients with gestational age above 28 weeks. We divided them into two groups; exposed and unexposed. The exposure studied was ingestion of TM within 72 h prior to delivery. Variables studied were socio-demographic characteristics, type and frequency of TM ingested and details of labour.

Results

We enrolled a total of 603 parturients of whom 147 in the exposed group and 456 in the non-exposed group. The most frequently used TM were honey and Triumfetta pentandra A. Ingestion of TM in the peri-paritum period was associated with intra-partum vaginal bleeding, dystocic labour, tachysystole and uterine atony. No adverse neonatal outcome was observed. Overall, these findings could help guide the direction of future research into the safety and potential benefits of peri-partum TM use, as well as serving as a preliminary reference for counselling.

Introduction

Traditional medicine (TM) is the sum of all knowledge, skills and practices that are based on the theories, beliefs and experiences of health preservation, specific to different cultures, whether explainable or not, which are used in health preservation, as well as in the prevention, diagnosis, improvement or treatment of physical or mental illness [1]. In TM, drugs of the traditional pharmacopoeia, called “herbal medicines” are used. As high as 80% of pregnant African women in Africa and the diaspora use TM to treat pregnancy related symptoms [2]. According to a study conducted in 2012 in Cameroon, 31.02% of women use TM during the second half of pregnancy [3]. However, its oral intake during pregnancy may be associated with obstetrical, foetal and neonatal complications. A study conducted in South Africa reported that the use of TM increased the rates of emergency cesarean and foetal distress [4]. There is a dearth of data on the impact of TM ingestion in the peri-partum period in Cameroon. Against this background, we conducted this study to determine the effects of the ingestion of TM during the peri-partum period on the maternal and foetal outcomes.

Main text

Methods

Study design, setting and participants

This was a prospective cohort study conducted from January 1 to April 30, 2016, in the maternity wards of two referral hospitals in Cameroon; the Gyneco-obstetrics and Pediatric Hospital of Yaoundé and the Central Hospital of Yaoundé. An exposed group (consisting of pregnant women who had ingested TM within 72 h prior to delivery or during labour) was compared to an unexposed group (pregnant women who had not ingested TM within 72 h prior to delivery or during labour). We excluded all parturients with a gestational age less than 28 weeks, those who did not consent to participate to the study, parturients in whom labour was induced, those with intrauterine fetal death prior to the onset of labour, those with multiple gestations, those who delivered before hospital admission and those undergoing elective cesarean section. The sampling method was exhaustive and consecutive. Assuming a 95% confidence interval (CI), a variability of 1.96, an accuracy of 0.05, 31.02% rate of TM use [3], the SCHULZ and GRIMES formula was used to obtain a minimum size of our sample of 89 subjects per group. The sampling method was exhaustive and consecutive.

Data collection

A pre-tested questionnaire was used to collect information on the socio-demographic characteristics (age, level of education, and marital status), TM details (type of TM ingested, frequency of intake and amount), labour details (reason for admission, duration of the second period of labour, use of oxytocins, complications during labour), delivery details (mode of delivery, APGAR score at the 1st and 5th min, delivery complications such as acute foetal distress and uterine atony).

Management of delivery

All deliveries occurred with women lying in the recumbent position with legs in holders. Fetal heart monitoring during delivery was done electronically by means of a cardiotocography machine.

Definition of terms

Foetal distress was defined as the occurrence of late or variable decelerations and reduce variability of foetal heart rate (less than 110 beats/min) [5, 6]. Blood loss was estimated and postpartum haemorrhage defined as an estimated blood loss greater than 500 mL within 24 h after vaginal delivery or greater than 1000 ml within 24 h of cesarean section [7, 8]. Dystocia was defined as slow or difficult labour related to inefficient uterine contractions, failure to progress, prolonged labour > 12 h, arrested descent and cephalopelvic disproportion [9, 10]. Uterine atony was defined as failure of the uterus to contract after delivery [11] while tachysystole was defined as more than five uterine contractions in 10 min for at least 30 min [12]. Neonatal asphyxia was defined based on the Modified Sarnat-Sarnat Score [13, 14].

Data analysis and management

The data was collected, recorded and analyzed using Epi-info 3.5.4 software. The categorical variables were compared using the Chi square test and the Fisher exact test when appropriate. The factors associated with the use of TM were identified by calculating the risk ratio (RR) with its 95% confidence interval (CI). The association between the use of TM and different variables was measured using the relative risks (RR) and its 95% confidence interval (CI). Logistic regression was performed for all variables whose p value was < 0.1.

Results

Incidence and reasons for ingestion of traditional medicine during peri-partum period

A total of 603 parturients met our inclusion criteria. One hundred and forty-seven (147) took TM 72 h preceding delivery or during labour (exposed group) and 456 who did not (the non-exposed group). Hence, the incidence rate of TM intake during the peri-partum period was 24.4%. The types of TM used by parturients are summarized in Table 1. The most frequently used TM was honey in 28.2% and Triumfetta pentandra A. (“nkui”) in 23.7% of the cases. Several parturients used a combination of TM. The main reasons for the ingestion of TM were to ease delivery (83.3%), to induce labour (21.36%) or to treat constipation (10%).

Table 1 Distribution of the list of Traditional Medicine used in terms of percentage use; reason for using and subjective perception

General characteristics of the study population

The ages of the parturients ranged from 15 to 45 years with an average of 28.88 ± 6.31 years in the exposed group and 27.90 ± 6.30 years in the non-exposed group The most represented age group was 25–34 years old. Table 2 shows the distribution of the population by age. With regards to marital status, 48.3% were singled and 36.5% married. Cohabitation was associated with TM ingestion during the peri-partum period (RR = 1.79, 95% CI 1.10–2.94, p = 0.016).

Table 2 General characteristics of the study population

Having at a secondary level of education was associated with not using TM prior to labour onset (RR = 0.68, 95% CI 0.47–0.99, p = 0.028). In contrast, having a tertiary level of education was associated with TM oral intake in the peri-partum period (RR = 1.58 95% CI 1.08–2.33, p = 0.012).

The influence of traditional medicine on labour

The most common reason for admission was labour pains in 57.4%. TM ingestion in the peri-partum period was associated with intra-partum vaginal bleeding (RR = 1.51, 95% CI = 1.10–2.08, p = 0.011) and dystocic labour (RR = 1.45, 95% CI = 1.10–1.91, p = 0.007). The estimated vaginal blood lost in all parturients did not meet our criteria for postpartum haemorrhage as defined in the methods. Furthermore, TM ingestion during labour was significantly associated with tachysystole (RR = 1.27, 95% CI = 1.06–1.52, p = 0.008) and uterine atony (RR = 7.24, 95% CI = 1.90–27.63, p = 0.002). All uterine atony observed were associated with excessive blood loss. There was no significant association between neonatal complications and TM intake as seen in Table 3.

Table 3 Logistic regression analysis of the influence of traditional medicine on labour and delivery

Discussion

This study aimed to determine the effects of TM oral intake during the peri-partum period on the maternal and foetal outcomes. We found that the ingestion TM within 72 h prior to delivery or during labour was significantly associated with vaginal bleeding prior to admission, tachysystole, dystocic delivery and uterine atony. TM use during the peri-partum period had no effect on foetal outcome.

Incidence of TM oral intake during labour and general characteristics of the study population

The incidence of TM ingestion in this study was 24.4%. This incidence is lower than that of Holst et al. in Sweden [15], Mabina et al. in South Africa [16] and Fakeye TO et al. in Nigeria [17] who observed incidence rates of use of TM of 36%, 55% and 67.5% respectively. This disparity could be explained by the fact that their incidences entail the use of TM during pregnancy and labour, compared to our study which focused on peri-partum use only. About eight different TM were reported to be ingested by parturients in our cohort, of which the most common were honey (28.2%), Triumfetta pentandra A. (23.7%), followed by the Hibiscus rosa-sinensis L (20%). Several parturients reported to use more than one TM during labour. This result is similar to that of Forster DA et al. in 2006 [18], who found an average TM combination of two per women. Congruent with the findings of Awouda et al. [3] and Azriani et al. [4], the main reason for TM consumption during labour was to ease delivery. The most represented age group was aged between 25–34 years. This is similar to the report of Hepner et al. in Massachusetts [19]; suggesting that the 25–34 years age group might be a potential target group to implement preventive strategies for TM use during pregnancy and labour.

Cohabitation was associated with TM ingestion prior to delivery or during labour. Although we could not find a plausible reason for this association, our results corroborate with those of Kofi AS in Ghana [20] and Fakeye TO et al. in Nigeria [21].

Secondary education was found to convey protection against TM use while tertiary education increased the odds of herbs intake during the peri-partum period. These results concur with those of several authors [15, 22,23,24,25]. This can be explained by the fact that women with a lower level of education are more likely to rely on the recommendations of their health care providers who do not often recommend TM use during gestation because of their unknown clinical efficacy or safety [2, 26,27,28].

The influence of traditional medicine on delivery

Amongst the complications of TM ingestion during labor, we observed a significant risk of tachysystole (p = 0.008). Although we did not precisely identify which TM had this effect, this may infer that TM have a uterotonic property. As for honey, previous studies [23] revealed that it contains oestrogen, which could explain this uterotonic action. Although there is little available data on the effects of oestrogen on the human uterus, evidences from animal studies has it that oestrogen augments uterine contractility via increasing myometrial excitability, augmenting myometrial sensitivity to uterotonics such as oxytocin, and increasing the production and secretion of prostaglandins by foetal membranes [29,30,31]. Furthermore, honey is rich in inhibin which acts in synergy to procure stronger uterine contractions [23]. However, honey also has some toxicity related to the presence of toxic alkaloids or andrometoxin, a toxin from the nectar of the colchicine plant [23]. As such, this increases the risk of uterine atony in the exposed group. Another possible explanation is that the hyperkinetic uterus becomes fatigued after sometime of intense contractions and eventually failing to contract, leading to uterine atony. Lastly, we did not observe any difference in adverse foetal outcomes between the exposed and unexposed groups. Concurring findings were made by Holst et al. [15], who observed correlation between herbal medicine oral intake and neonatal complications.

Conclusion

Overall, we found that about one parturient out of every four uses TM during labour. Some socio-demographic characteristics such as liberal union and tertiary level of education predispose pregnant women to TM ingestion during labour. TM oral intake during the peri-partum period was associated with vaginal bleeding prior to consultation, tachysystole, dystocic delivery and uterine atony.

Limitations

The findings from the current study should be interpreted within the context of its limitations. These include the inability of 12.3% parturients to precisely identity what type of TM was taken prior to delivery or during labour (Table 1). Furthermore, TM oral intake during labour had no effect on foetal outcome perharbs due to the fact that the study was grossly underpowered to detect any significant differences in foetal outcomes such as stillbirth, hypoxia-ischemia, cerebral palsy, that are extremely rare events. Also, as the study population was drawn from only two referral maternities of Cameroon, this implies cautious generalization of the current findings. However, based on a large sample (n = 603) of well followed-up parturients, we have used robust statistical methods to contribute data on the contemporary scarcity of evidence the effects of peri-partum ingestion of TM on the maternal and foetal outcomes in the tropics. These findings could help guide the direction of future research into the safety and potential benefits of peripartum TM use, as well as serving as a preliminary reference for counselling pregnant women and obstetricians on TM use in obstetrics.

Abbreviations

TM:

traditional medicine

References

  1. 1.

    World Health Organization: Factsheet 134: traditional medicine. Geneva: World Health Organization; 2013. http://www.who.int/mediacentre/factsheets/2003/fs134/en/.

  2. 2.

    Shewamene Z, Dune T, Smith CA. The use of traditional medicine in maternity care among African women in Africa and the diaspora: a systematic review. BMC Complement Altern Med. 2017;17:382.

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Awouda N. Traditional medicine use in the second half of pregnancy and outcome of labour [Medicine thesis]. Yaounde : University of Yaounde I, Faculty of Medicine and Biomedical Sciences; 2012, p. 178.

  4. 4.

    Azriani A, Siti A, Zulkifli A, Halim S, Wan N, Abdul M. Women’s attitude and socio-demographic characteristics influencing usage of herbal medicine during pregnancy in Tumpat district, Kelantan. South Eastern Asian. J Trop Med Public Health. 2009;40(1):330–7.

    Google Scholar 

  5. 5.

    American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 326. Inappropriate use of the terms fetal distress and birth asphyxia. Obstet Gynecol. 2005;106(6):1469–70.

    Article  Google Scholar 

  6. 6.

    Tochie JN, Choukem S-P, Langmia RN, Barla E, Koki-Ndombo P. Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes. Pan Afr Med J. 2016;24:152.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Stafford I, Dildy GA, Clark SL, et al. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199(519):e1–7.

    Google Scholar 

  8. 8.

    Dohbit JS, Foumane P, Nkwabong E, Kamouko CO, Tochie JN, Otabela B, Mboudou E. Uterus preserving surgery versus hysterectomy in the treatment of refractory postpartum haemorrhage in two tertiary maternity units in Cameroon: a cohort analysis of perioperative outcomes. BMC Preg Childb. 2017;17:158.

    Article  Google Scholar 

  9. 9.

    Neal JL, Ryan SL, Lowe NK, Schorn MN, Buxton M, Holley SL, Wilson-Liverman AM. Labor dystocia: uses of related nomenclature. J Midwifery Womens Health. 2015;60(5):485–98.

    PubMed  Article  Google Scholar 

  10. 10.

    Dohbit JS, Foumane P, Tochie JN, Mamoudou F, Temgoua NM, Tankeu R, et al. Maternal and neonatal outcomes of vaginal breech delivery for singleton term pregnancies in a carefully selected Cameroonian population: a cohort study. BMJ Open. 2017;7:e017198. https://doi.org/10.1136/bmjopen-2017-017198.

    PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Breathnach F, Geary M. Uterine atony: definition, prevention, nonsurgical management, and uterine tamponade. Semin Perinatol. 2009;33(2):82–7.

    PubMed  Article  Google Scholar 

  12. 12.

    National Institute for Clinical Excellence. Uterine hyperstimulation: foetal management guidelines D. London: NICE; 2009.

    Google Scholar 

  13. 13.

    Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696–705.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Ndombo PK, Ekei QM, Tochie JN, Temgoua MN, Angong FTE, Ntock FN, Mbuagbaw L. A cohort analysis of neonatal hospital mortality rate and predictors of neonatal mortality in a sub-urban hospital of Cameroon. Ital J Pediatr. 2017;43:52.

    PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Holst L, Wright D, Haavik S, Nordeng H. The use and the user of herbal remedies during pregnancy. J Altern Complement Med. 2009;15(7):787–92.

    PubMed  Article  Google Scholar 

  16. 16.

    Mabina M, Pitsoe S, Moodley J. The effect of traditional herbal medicines on pregnancy outcome. S Afr Med J. 1997;87(8):1008–10.

    CAS  PubMed  Google Scholar 

  17. 17.

    Fakeye TO, Adisa R, Musa IE. Attitude and use of herbal medicines among pregnant women in Nigeria. BMC Compl Altern Med. 2009;9:53.

    Article  Google Scholar 

  18. 18.

    Forster DA, Denning A, Wills G, Bolger M, McCarthy E. Herbal medicine use during pregnancy in a group of Australian women. BMC Preg Childb. 2006;6:21.

    Article  Google Scholar 

  19. 19.

    Hepner D, Harnett M, Segal S, Camann W, Bader A, Tsen L. Herbal medicine use in parturients. Anesth Analg. 2002;94(3):690–3.

    PubMed  Article  Google Scholar 

  20. 20.

    Kofi Alor Stanley. Traditional medicine usage in pregnancy. Med Res Clin Case Rep. 2018;2(3):201–17.

    Google Scholar 

  21. 21.

    Fakeye TO, Onyemadu O. Evaluation of knowledge base of hospital pharmacists and physicians on herbal medicines in Southwestern Nigeria. Pharm Pract. 2008;6(2):88–92.

    Google Scholar 

  22. 22.

    Steel A, Adams J, Sibbritt D, Broom A, Gallois C, Frawley J. Utilisation of complementary and alternative medicine (CAM) practitioners within maternity care provision: results from a nationally representative cohort study of 1835 pregnant women. BMC Preg Birth. 2012;12(1):146.

    Article  Google Scholar 

  23. 23.

    Nordeng H, Havnen GC. Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol Scand. 2005;84(1):26–33.

    PubMed  Article  Google Scholar 

  24. 24.

    Gibson P, Powrie R, Star J. Herbal and alternative medicine use during pregnancy: a cross sectional survey. Obstet Gynecol. 2001;97(2):44–5.

    Google Scholar 

  25. 25.

    Mohammadreza S, Maryam D, Hadi H, Simin OM. Self-reported use and attitudes regarding herbal medicine safety during pregnancy. J Altern Sci. 2012;7(2):45–9.

    Google Scholar 

  26. 26.

    Jimam NS, Joseph BN, Agba DC. Pharmacists’ knowledge and perceptions about herbal medicines: a case study of Jos and environs. Med J DY Patil Univ. 2017;10:229–33.

    Article  Google Scholar 

  27. 27.

    Pakrashi A, Bhattacharya N. Abortifacient principle of Achyranthes aspera Linn. Indian J Exp Biol. 1977;15(10):856–8.

    CAS  PubMed  Google Scholar 

  28. 28.

    Mothupi MC. Use of herbal medicine during pregnancy among women with access to public healthcare in Nairobi, Kenya: a cross-sectional survey. BMC Compl Altern Med. 2014;14:432.

    Article  Google Scholar 

  29. 29.

    Mueller A, Siemer J, Schreiner J, Koesztner H, Hoffmann I, Binder H, Beckmann MW, Dittrich R. Role of estrogen and progesterone in the regulation of uterine peristalsis: results from perfused non-pregnant swine uteri. Hum Reprod. 2006;21(7):1863–8.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Mesiano S. Roles of estrogen and progesterone in human parturition. In: Smith R, editor. The endocrinology of parturition. Basic science and clinical application. Karger: Front Horm Res; 2001. p. 86–104.

    Google Scholar 

  31. 31.

    Cross DT, Ginther OJ. The effect of estrogen, progesterone and prostaglandin F2α on uterine contractions in seasonally anovulatory mares. Domest Anim Endocrinol. 1987;4(4):271–8.

    CAS  PubMed  Article  Google Scholar 

Download references

Authors’ contributions

JSD, EM and JNT: Study conception and design, acquisition of data, data analysis and interpretation, manuscript writing and critical revisions. MKMZ : Study design, acquisition of data, data analysis and interpretation, and manuscript writing. FE, VNA, JRN and PF: data analysis and interpretation, manuscript writing and critical revisions of the manuscript for intellectual content. All authors read and approved the final manuscript.

Acknowledgements

The authors thank all the staff of the Maternity units of the Yaoundé Central Hospital and the Yaounde of the Gyneco-Obstetrics and Pediatric Hospital of Yaoundé for partaking in the care of all the participants included in this study. We also acknowledge the study participants for their commitment.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study was approved by the Institutional Review Board of the Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon under the ethical clearance No. 192/CIERSH/DM/2016. Administrative authorizations were equally obtained from the administration of both hospitals involved prior to the beginning of the study. Written consent to participate was obtained from all participants prior to their enrolment into the study. For pregnant women aged below 16 years, written informed consent was obtained from their parents or guardians.

Funding

Not applicable.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Joel Noutakdie Tochie.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dohbit, J.S., Meka, E., Tochie, J.N. et al. Exploring the effects of peri-partum ingestion of traditional medicine on maternal and foetal outcomes: a prospective cohort study. BMC Res Notes 12, 166 (2019). https://doi.org/10.1186/s13104-019-4199-y

Download citation

Keywords

  • Traditional medicine
  • Labour
  • Maternal
  • Foetal
  • Outcome